Evidence-Based Medicine Guidelines
Rivastigmine for vascular cognitive impairment
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rivastigmine for Vascular Cognitive Impairment." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458136/all/Rivastigmine_for_vascular_cognitive_impairment.
Rivastigmine for vascular cognitive impairment. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/458136/all/Rivastigmine_for_vascular_cognitive_impairment. Accessed November 26, 2024.
Rivastigmine for vascular cognitive impairment. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458136/all/Rivastigmine_for_vascular_cognitive_impairment
Rivastigmine for Vascular Cognitive Impairment [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458136/all/Rivastigmine_for_vascular_cognitive_impairment.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rivastigmine for vascular cognitive impairment
ID - 458136
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458136/all/Rivastigmine_for_vascular_cognitive_impairment
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
